[Cu2Cl2(4′-(4-Methoxy-1-naphthyl)-terpy)2](PF6)2 | MedChemExpress (MCE)
[Cu2Cl2(4′-(4-Methoxy-1-naphthyl)-terpy)2](PF6)2 (Compound 3) is a copper complex, which inhibits cell viability of HCT116, HCT116DoxR, A2780 and fibroblasts, with IC50s of 0.13, 0.15, 0.66 and 6.24 μM, respectively. [Cu2Cl2(4′-(4-Methoxy-1-naphthyl)-terpy)2](PF6)2 induces apoptosis and autophagy, and arrests cell cycle at G0/G1 phase in HCT116DoxR. [Cu2Cl2(4′-(4-Methoxy-1-naphthyl)-terpy)2](PF6)2 exhibits antimetastatic efficacy[1].
Trivial name | [Cu2Cl2(4'-(4-Methoxy-1-naphthyl)-terpy)2](PF6)2 |
Catalog Number | HY-158117 |
Research Area | Cancer |
Purity | ≥98.0% |
SMILES | COC1=C2C(C=CC=C2)=C(C=C1)C3=CC(C4=[N]5C=CC=C4)=[N]6C(C7=CC=CC=[N]7[Cu]658Cl[Cu]9%10([N]%11=CC=CC=C%11C%12=CC(C%13=C%14C=CC=CC%14=C(C=C%13)OC)=CC(C%15=CC=CC=[N]%15%10)=[N]%129)Cl8)=C3.[F-][P+5]([F-])([F-])([F-])([F-])[F-].[F-][P+5]([F-])([F-])([F-])([F-])[F-].[2+] |
Size | 1 mg |
Supplier Page | https://www.medchemexpress.com/cu2cl2-4-4-methoxy-1-naphthyl-terpy-2-pf6-2.html |